Resultado da Busca
Há 5 dias · The MSI-H phenotype is well represented in a subset of GI cancers, according to classifications by The Cancer Genome Atlas. 1 MSI-H tumors are seen to some degree in the middle to upper esophagus, but their presence increases in the stomach, attains the highest frequency in the right colon, and begins to diminish in the left colon and rectum.
Há 14 horas · Zebrafish patient-derived xenograft models (zAvatar) can be used to study cancer biology as well as to predict patient clinical outcomes and response to therapies. Here, in a cohort of 55 patients ...
Há 2 dias · Cercek A, Lumish M, Sinopoli J, et al. PD-1 Blockade in Mismatch Repair-Deficient, Locally Advanced Rectal Cancer. N Engl J Med. 2022;386(25):2363-2376. National Comprehensive Cancer Network. Clinical Practice Guidelines in Oncology (NCCN Guidelines®) for Rectal Cancer Version 2.2024.
Há 3 dias · NCCN, drawing on the expertise of faculty from its 21 member institutions, has developed and maintains clinical practice guidelines addressing colon and rectal cancers as part of its complete library of NCCN Clinical Practice Guidelines in Oncology™.
Há 4 dias · NCCN Colon and Rectal Cancers Guidelines Update. Review the latest updates to the NCCN Guidelines for colon and rectal cancers. Authors: Paul F. Engstrom, MD. Log In to Start. THIS ACTIVITY HAS EXPIRED FOR CREDIT. Target Audience and Goal Statement.
Há 1 dia · Fokas E, Schlenska-Lange A, Polat B, et al; German Rectal Cancer Study Group. Chemoradiotherapy plus induction or consolidation chemotherapy as total neoadjuvant therapy for patients with locally advanced rectal cancer: long-term results of the CAO/ARO/AIO-12 randomized clinical trial.
Há 14 horas · This was conducted in both Europe and the US and looked at the addition of bevacizumab. Here again, we have a positive trial in refractory colorectal cancer, which obviously is always encouraging ...
